연구동향 분석

Risk-Reducing Genetic Variant of Wilms Tumor 1 Gene rs16754 in Korean Patients With BCR-ABL1-Negative Myeloproliferative Neoplasm

김인숙 장철훈 강정은 김남희 이은엽 신호진 2015년

논문상세정보
인용/피인용
' Risk-Reducing Genetic Variant of Wilms Tumor 1 Gene rs16754 in Korean Patients With BCR-ABL1-Negative Myeloproliferative Neoplasm' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • myeloproliferative neoplasm
  • rs16754
  • wt1
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,589 0

0.0%

' Risk-Reducing Genetic Variant of Wilms Tumor 1 Gene rs16754 in Korean Patients With BCR-ABL1-Negative Myeloproliferative Neoplasm' 의 참고문헌

  • Wilms’ tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study
    Paschka P J Clin Oncol 26 : 4595 ~ 4602 [2008]
  • Wilms’ tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study
    Paschka P J Clin Oncol 26 4595-4602 [2008]
  • WT1synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children’s oncology group
    Ho PA J Clin Oncol 29 704-711 [2011]
  • WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-riskpediatric acute myeloid leukemia: a report from the children’s oncology group
    Ho PA J Clin Oncol 29 : 704 ~ 711 [2011]
  • WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survivalscoring system
    Hou HA Blood 115 : 5222 ~ 5231 [2010]
  • WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survivalscoring system
    Hou HA Blood 115 5222-5231 [2010]
  • The Wilms’ tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes
    Tamaki H Leukemia 13 : 393 ~ 399 [1999]
  • The Wilms’ tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes
    Tamaki H Leukemia 13 393-399 [1999]
  • The 2008 revision of the world health organization(who)classification of myeloid neoplasms and acute leukemia : Rationale and important changes
    Vardiman JW Blood 114 : 937 ~ 951 [2009]
  • The 2008 revision of the world health organization(who)classification of myeloid neoplasms and acute leukemia : Rationale and important changes
    Vardiman JW Blood 114 937-951 [2009]
  • Single nucleotide polymorphism of Wilms’ tumor 1 gene rs16754 in Korean patients with cytogenetically normal acute myeloid leukemia
    Choi Y Ann Hematol 91 : 671 ~ 677 [2012]
  • Single nucleotide polymorphism of Wilms’ tumor 1 gene rs16754 in Korean patients with cytogenetically normal acute myeloid leukemia
    Choi Y Ann Hematol 91 671-677 [2012]
  • Single nucleotide polymorphism in the mutational hotspot of WT1predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia
    Damm F J Clin Oncol 28 578-585 [2010]
  • Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia
    Damm F J Clin Oncol 28 : 578 ~ 585 [2010]
  • No prognostic impact of the WT1 gene single nucleotide polymorphism rs16754 in pediatric acute myeloid leukemia
    Hollink IH J Clin Oncol 28 : e523 ~ 526 [2010]
  • No prognostic impact of the WT1 gene single nucleotide polymorphism rs16754 in pediatric acute myeloid leukemia
    Hollink IH J Clin Oncol 28 e523-526 [2010]
  • Integrating common and rare genetic variation in diverse human populations
    Altshuler DM Nature 467 : 52 ~ 58 [2010]
  • Integrating common and rare genetic variation in diverse human populations
    Altshuler DM Nature 467 52-58 [2010]
  • Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
    Becker H Haematologica 96 : 1488 ~ 1495 [2011]
  • Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
    Becker H Haematologica 96 1488-1495 [2011]
  • Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms
    Tefferi A Leukemia 22 : 14 ~ 22 [2008]
  • Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms
    Tefferi A Leukemia 22 14-22 [2008]
  • A tumor suppressor and oncogene: the WT1 story
    Yang L Leukemia 21 : 868 ~ 876 [2007]
  • A tumor suppressor and oncogene: the WT1 story
    Yang L Leukemia 21 868-876 [2007]